RayzeBio
,
the radiopharmaceutical therapeutics company, rose 101% to $61.40 after reaching an agreement to be acquired by
for $62.50 a share in cash. The deal was valued at $4.1 billion.
closed Friday at $30.57. Bristol Myers shares were down 1.6%.
U.S.-listed shares of
surged 60% to $9.92 after the Shanghai-based biopharmaceutical company reached an agreement to be acquired by
in a transaction valued at up $1.2 billion. Gracell shareholders will receive $2 ordinary share (equivalent to $10 per American depositary share) in cash, plus an additional share-purchase contingent.
was up slightly.
U.S.-listed shares of
rose 11% after the Chinese electric-vehicle maker over the weekend unveiled the ET9, a four-seat executive sedan. The starting price for the car is $112,780. Deliveries of the sedan won’t begin until early 2025.
Advertisement – Scroll to Continue
was up 5.2% after it was confirmed the chip maker would invest $25 billion in Israel to expand its wafer fabrication site after receiving $3.2 billion from the country’s government.
rose 3.4% to $20.52 after British billionaire Jim Ratcliffe agreed to buy a minority stake in the professional soccer club. Ratcliffe will acquire 25% of
Class B shares and up to 25% of the club’s Class A shares and provide an additional $300 million for future investment into soccer stadium Old Trafford, Manchester United said in a statement.
was up 1.6% to $73.41 after the price target on shares of the chip designer were raised to $110 from $85 by analysts at Rosenblatt Securities, who maintained their Buy rating on the stock. Rosenblatt’s target is the highest on Wall Street, according to FactSet.
rose 1.6% after the shipping company announced a $1 billion accelerated share repurchase program. Rival
Advertisement – Scroll to Continue
was downgraded to Neutral from Outperform with a $155 price target at Daiwa Capital. The stock fell 0.1% to $158.03.
Hollysys Automation Technologies
was up 5.2% after a consortium led by Dazheng Group Acquisition submitted a higher all-cash offer to acquire the automation control system solutions provider for $1.8 billion. Hollysys agreed to be acquired by private investment firm Ascendent Capital Partners earlier this month, with its board approving the $1.66 billion deal.
Write to Joe Woelfel at joseph.woelfel@barrons.com
